Effects of a tricaprylin emulsion on anti-glomerular basement membrane glomerulonephritis in rats: In vivo and in silico studies

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 8, 2015, Pages 1175-1184

  Liu, Ning ^a   Shi, Junfeng ^a   Xiao, Ying ^a   Yasue, Misato ^a   Takei, Yoshinori ^a   Sanefuji, Hayato ^b   Tsujimoto, Gozoh ^a   Hirasawa, Akira ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b Department of Urology   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Crescentic glomerulonephritis; Gene ontology; Microarray; Tricaprylin

Indexed keywords

CASEIN KINASE II; CREATININE; EMODIN; NITROGEN; TRIOCTANOIN; UREA; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY; AUTOANTIBODY; EMULSION; OCTANOIC ACID DERIVATIVE; TRANSCRIPTOME; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMULSION; GENE EXPRESSION; GENE ONTOLOGY; GLOMERULONEPHRITIS; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; NONHUMAN; PROTEINURIA; RAT; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; COMPUTER SIMULATION; DRUG EFFECTS; GLOMERULUS BASEMENT MEMBRANE; INBRED RAT STRAIN; KIDNEY; KIDNEY FAILURE, CHRONIC; PATHOLOGY;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; CAPRYLATES; COMPUTER SIMULATION; EMULSIONS; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MICROARRAY ANALYSIS; RATS, INBRED STRAINS; TRANSCRIPTOME; TRIGLYCERIDES;

EID: 84940914025     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00124     Document Type: Article

References (35)

1. Li X, Chen N. Management of crescentic glomerulonephritis: what are the recent advances? Contrib. Nephrol., 181, 229-239 (2013).
2. Yamada M, Katsuma S, Adachi T, Hirasawa A, Shiojima S, Kadowaki T, Okuno Y, Koshimizu TA, Fujii S, Sekiya Y, Miyamoto Y, Tamura M, Yumura W, Nihei H, Kobayashi M, Tsujimoto G. Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc. Natl. Acad. Sci. U.S.A., 102, 7736-7741 (2005).
3. Durvasula RV, Shankland SJ. Models of glomerulonephritis. Methods Mol. Med., 86, 47-66 (2003).
4. Tipping PG. Crescentic nephritis-is it in your genes? Nephrol. Dial. Transplant., 23, 3065-3066 (2008).
5. Liu N, Makino T, Nogaki F, Kusano H, Suyama K, Muso E, Honda G, Kita T, Ono T. Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats. Am. J. Physiol. Renal Physiol., 287, F612-F620 (2004).
6. Krakower CA, Nicholes BK, Greenspon SA. Proteinuria and the fragility of normal and diseased glomerular basement membrane. Proc. Soc. Exp. Biol. Med., 159, 324-334 (1978).
7. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int., 54, 416-425 (1998).
8. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S. Mesangial factor V expression colocalized with fibrin deposition in IgA ne ph ropathy. Kidney Int., 58, 598-606 (2000).
9. Nakaniwa T, Kinoshita T, Sekiguchi Y, Tada T, Nakanishi I, Kitaura K, Suzuki Y, Ohno H, Hirasawa A, Tsujimoto G. Structure of human protein kinase CK2 alpha 2 with a potent indazole-derivative inhibitor. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 65, 75-79 (2009).
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
11. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501 (1992).
12. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Korner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Levy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature, 483, 350-354 (2012).
13. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol., 5, R80 (2004).
14. Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics, 18, 1585-1592 (2002).
15. Boyle EI, Weng S, Gollub J, Jin H, Botstein D, Cherry JM, Sherlock GGO. TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics, 20, 3710-3715 (2004).
16. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A., 102, 15545-15550 (2005).
17. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res., 30, 42-46 (2002).
18. Battistutta R, Sarno S, De Moliner E, Papinutto E, Zanotti G, Pinna LA. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. J. Biol. Chem., 275, 29618-29622 (2000).
19. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol., 182, 311-322 (2000).
20. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology, 54, 589-599 (1985).
21. Yoshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol., 142, 1956-1962 (1989).
22. Oshida K, Hirakata M, Maeda A, Miyoshi T, Miyamoto Y. Toxicological effect of emodin in mouse testicular gene expression profile. J. Appl. Toxicol., 31, 790-800 (2011).
23. Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, Bottinger EP, Segerer S, Lindenmeyer M, Cohen CD, Davidson A, Kretzler M. Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. J. Immunol., 189, 988-1001 (2012).
24. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G, The Gene Ontology Consortium. Geneontology: tool for the unification of biology. Nat. Genet., 25, 25-29 (2000).
25. Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE, Mueller W. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumour cell proliferation. J. Pathol., 200, 16-22 (2003).
26. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell, 3, 421-429 (2003).
27. Pemberton HN, Franklyn JA, Boelaert K, Chan SY, Kim DS, Kim C, Cheng SY, Kilby MD, McCabe CJ. Separase, securin and Rad21 in neural cell growth. J. Cell. Physiol., 213, 45-53 (2007).
28. Fassett RG, Gobe GC, Peake JM, Coombes JS. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am. J. Kidney Dis., 56, 728-742 (2010).
29. Fu Y, Du Y, Mohan C. Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin. Immunol., 124, 109-118 (2007).
30. Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sanchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ramon E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly R P, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA, Wakeland EK, Alarcón-Riquelme ME, Mohan C, Profile Study Group, Italian Collaborative Group, German Collaborative Group, Spanish Collaborative Group, Argentinian Collaborative Group, SLEGEN Consortium. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J. Clin. Invest., 119, 911-923 (2009).
31. Harbeck RJ, Launder T, Staszak C. Mononuclear cell pulmonary vasculitis in NZB/W mice. II. Immunohistochemical characterization of the infiltrating cells. Am. J. Pathol., 123, 204-211 (1986).
32. Kastantin M, Missirlis D, Black M, Ananthanarayanan B, Peters D, Tirrell M. Thermodynamic and kinetic stability of DSPE-PEG(2000) micelles in the presence of bovine serum albumin. J. Phys. Chem. B, 114, 12632-12640 (2010).
33. Chin HJ, Fu YY, Ahn JM, Na KY, Kim YS, Kim S, Chae DW. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. Nephrol. Dial. Transplant., 25, 1450-1457 (2010).
34. Hara T, Kashihara D, Ichimura A, Kimura I, Tsujimoto G, Hirasawa A. Role of free fatty acid receptors in the regulation of energy metabolism. Biochim. Biophys. Acta, 1841, 1292-1300 (2014).
35. Liberato MV, Nascimento AS, Ayers SD, Lin JZ, Cvoro A, Silveira RL, Martinez L, Souza PC, Saidemberg D, Deng T, Amato AA, Togashi M, Hsueh WA, Phillips K, Palma MS, Neves FA, Skaf MS, Webb P, Polikarpov I. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR)-gamma activators and pan-PPAR partial agonists. PLoS ONE, 7, e36297 (2012).